Effect of multimodal CT angiography/perfusion sequencing on alteplase door-to-needle time

BACKGROUND AND PURPOSE: Multimodal computed tomography angiography and perfusion (CTA/CTP) is increasingly used in the emergency department (ED) evaluation of acute ischemic stroke (AIS) but may delay thrombolysis. We examined whether the sequencing of multimodal CTA/CTP relative to thrombolytic administration affects door-to-needle (DTN) time. METHODS: We conducted a retrospective cohort study of adult patients with AIS treated with intravenous alteplase at a tertiary, academically affiliated ED that is part of a certified Comprehensive Stroke Center between January 1, 2012, and August 1, 2023. All patients underwent an initial noncontrast CT (NCCT), followed by either a contrast-first workflow (i.e. CTA/CTP) or were given alteplase before proceeding to contrast administration. The primary outcome was DTN time, analyzed using univariate methods and multivariable quantile regression adjusting for stroke severity, pre-alteplase antihypertensive use, thrombectomy (as a correlate for large-vessel occlusion), primary language, and bedside ED pharmacist presence. RESULTS: Among 1,382 AIS encounters, 167 patients met inclusion criteria; 148 underwent CTA/CTP before alteplase and 19 received alteplase before contrast administration. Median DTN time was significantly shorter in the alteplase-first group (20 minutes [interquartile range (IQR), 15-26]) compared with the CTA/CTP-first group (44 minutes [IQR, 32-56]; P<0.001). After adjustment, alteplase-first administration remained independently associated with faster DTN time (-25 minutes; 95% CI, -34 to -16). Higher stroke severity and ED pharmacist presence were also associated with shorter DTN, whereas pre-alteplase antihypertensives, primary language, and thrombectomy were not. CONCLUSIONS: A contrast-first strategy incorporating multimodal CTA/CTP before alteplase administration was associated with approximately twofold longer DTN times. These findings suggest that obtaining CTA/CTP before thrombolytic administration may substantially prolong DTN times. Larger studies are needed to confirm the magnitude of this association and to identify patient populations most likely to benefit from alternative imaging workflows.

Authors

Institutions

Publication Details

Journal
BMC Neurology
Published
2026-06-30
DOI
https://doi.org/10.1186/s12883-026-05105-y
Primary Topic
Acute Ischemic Stroke Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Effect of multimodal CT angiography/perfusion sequencing on alteplase door-to-needle time

Zlatan Coralic, Benjamin Michaels, Anthony S. Kim, Ralph Wang et al.
BMC Neurology
Acute Ischemic Stroke Management
article

Effect of multimodal CT angiography/perfusion sequencing on alteplase door-to-needle time

Zlatan Coralic, Benjamin Michaels, Anthony S. Kim, Ralph Wang, S. Andrew Josephson, Kenneth Truong
article en

Abstract

BACKGROUND AND PURPOSE: Multimodal computed tomography angiography and perfusion (CTA/CTP) is increasingly used in the emergency department (ED) evaluation of acute ischemic stroke (AIS) but may delay thrombolysis. We examined whether the sequencing of multimodal CTA/CTP relative to thrombolytic administration affects door-to-needle (DTN) time. METHODS: We conducted a retrospective cohort study of adult patients with AIS treated with intravenous alteplase at a tertiary, academically affiliated ED that is part of a certified Comprehensive Stroke Center between January 1, 2012, and August 1, 2023. All patients underwent an initial noncontrast CT (NCCT), followed by either a contrast-first workflow (i.e. CTA/CTP) or were given alteplase before proceeding to contrast administration. The primary outcome was DTN time, analyzed using univariate methods and multivariable quantile regression adjusting for stroke severity, pre-alteplase antihypertensive use, thrombectomy (as a correlate for large-vessel occlusion), primary language, and bedside ED pharmacist presence. RESULTS: Among 1,382 AIS encounters, 167 patients met inclusion criteria; 148 underwent CTA/CTP before alteplase and 19 received alteplase before contrast administration. Median DTN time was significantly shorter in the alteplase-first group (20 minutes [interquartile range (IQR), 15-26]) compared with the CTA/CTP-first group (44 minutes [IQR, 32-56]; P<0.001). After adjustment, alteplase-first administration remained independently associated with faster DTN time (-25 minutes; 95% CI, -34 to -16). Higher stroke severity and ED pharmacist presence were also associated with shorter DTN, whereas pre-alteplase antihypertensives, primary language, and thrombectomy were not. CONCLUSIONS: A contrast-first strategy incorporating multimodal CTA/CTP before alteplase administration was associated with approximately twofold longer DTN times. These findings suggest that obtaining CTA/CTP before thrombolytic administration may substantially prolong DTN times. Larger studies are needed to confirm the magnitude of this association and to identify patient populations most likely to benefit from alternative imaging workflows.

BMC Neurology
University of California, San Francisco (US), University of San Francisco (US)
Quality Education
Openalex Percentile: Top 8%
Acute Ischemic Stroke Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.